[Management of severe pre-eclampsia in the puerperium. Comparative study of sublingual nifedipine and hydralazine].
At random, two therapeutic schemes for severe preeclampsia during the puerperium, were evaluated. Group A (n = 20) was left without antihypertensive medication and sublingual nifedipine was used only in case of diastolic pressure of 110 mmHg or more. Group B (n = 18) receive Hydralazine 40 mlg. per os, every 6 hrs.; in this group also, nifedipine was administered in case of diastolic pressure of 110 mmHg or more. The only differences were that in group B the intervals for the administration of nifedipine were much shorter than in group A; also, in the same group the need for another antihypertensive was more frequent (5 of 18 vs 1 of 20 patients).
Walss Rodríguez
R J
RJ
Centro Médico Nacional Torreón, IMSS, Coah.
Villarreal Ordaz
F
F
D000286:Administration, Sublingual; D000293:Adolescent; D000328:Adult; D000959:Antihypertensive Agents / Q000008:administration & dosage / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006830:Hydralazine / Q000627:therapeutic use*; D009543:Nifedipine / Q000008:administration & dosage / Q000627:therapeutic use*; D011225:Pre-Eclampsia / Q000188:drug therapy*; D011247:Pregnancy; D011644:Puerperal Disorders / Q000188:drug therapy*
D000959:Antihypertensive Agents; D006830:Hydralazine; D009543:Nifedipine
Manejo de preeclampsia severa en el puerperio. Estudio comparativo entre nifedipina sublingual e hidralazina.